AMGN · News · 20261104N

Net Income and EPS Performance

AMGEN INC · 2026-11-04 · Importance 25 · Surprise 22

Amgen reported Q3 2026 GAAP EPS of $7.08, up 19% year over year, and GAAP net income of $3.86 billion. Adjusted earnings were $6.45 per share, a 14% year-over-year increase, and exceeded the Zacks consensus estimate of $5.74. Revenue of $10.37 billion also surpassed the $9.95 billion consensus estimate.

Key facts

• Amgen's Q3 2026 adjusted earnings were $6.45 per share, up 14% year over year, and beat the Zacks Consensus Estimate of $5.74 per share. source
• Amgen's Q3 2026 GAAP EPS rose 19% to $7.08. source
• Amgen's Q3 2026 adjusted EPS was $6.45 against a $5.76 estimate, a positive difference of 11.98%, and revenue was $10.40 billion against $10.06 billion. source